JP2006504737A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504737A5
JP2006504737A5 JP2004543233A JP2004543233A JP2006504737A5 JP 2006504737 A5 JP2006504737 A5 JP 2006504737A5 JP 2004543233 A JP2004543233 A JP 2004543233A JP 2004543233 A JP2004543233 A JP 2004543233A JP 2006504737 A5 JP2006504737 A5 JP 2006504737A5
Authority
JP
Japan
Prior art keywords
compound
chromeno
difluoro
quinoline
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504737A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/024420 external-priority patent/WO2004033461A1/en
Publication of JP2006504737A publication Critical patent/JP2006504737A/ja
Publication of JP2006504737A5 publication Critical patent/JP2006504737A5/ja
Pending legal-status Critical Current

Links

JP2004543233A 2002-10-11 2003-08-04 選択的プロゲステロン受容体モジュレーターとしての5−置換7,9−ジフルオロ−5H−クロメノ[3,4−f]キノリン化合物 Pending JP2006504737A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41796802P 2002-10-11 2002-10-11
PCT/US2003/024420 WO2004033461A1 (en) 2002-10-11 2003-08-04 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATORS

Publications (2)

Publication Number Publication Date
JP2006504737A JP2006504737A (ja) 2006-02-09
JP2006504737A5 true JP2006504737A5 (enExample) 2006-09-21

Family

ID=31994318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543233A Pending JP2006504737A (ja) 2002-10-11 2003-08-04 選択的プロゲステロン受容体モジュレーターとしての5−置換7,9−ジフルオロ−5H−クロメノ[3,4−f]キノリン化合物

Country Status (12)

Country Link
US (1) US7163946B2 (enExample)
EP (1) EP1554283A1 (enExample)
JP (1) JP2006504737A (enExample)
AR (1) AR040781A1 (enExample)
AU (1) AU2003258051A1 (enExample)
CA (1) CA2501834A1 (enExample)
CL (1) CL2003001545A1 (enExample)
DE (1) DE20301728U1 (enExample)
HK (1) HK1055059A2 (enExample)
MX (1) MXPA05003801A (enExample)
TW (1) TW200413384A (enExample)
WO (1) WO2004033461A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AU2003258050A1 (en) * 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
EP1558618A1 (en) * 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
MX2021000377A (es) * 2018-07-12 2021-03-25 Lilly Co Eli Degradadores selectivos del receptor de estrogeno.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635941A (en) 1969-04-01 1972-01-18 Eastman Kodak Co Disperse mono azo dyes containing an acylamidotetrahydroquinoline group
US3907507A (en) * 1971-04-26 1975-09-23 Heliodoro Monroy Rivera Novel apparatus for the obtention of substituted 1,2-dihydroquinolines
DK1130017T3 (da) 1990-11-30 2005-10-10 Otsuka Pharma Co Ltd Azolderivater og deres anvendelse som superoxidradikalinhibitorer
JPH04316557A (ja) 1991-04-16 1992-11-06 Kyorin Pharmaceut Co Ltd 6−アリール環状アントラニル酸誘導体
US5506102A (en) * 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription
US5693646A (en) * 1994-12-22 1997-12-02 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
ATE269336T1 (de) 1994-12-22 2004-07-15 Ligand Pharm Inc Steroidrezeptor-modulator verbindungen und methoden
US6696459B1 (en) * 1994-12-22 2004-02-24 Ligand Pharmaceuticals Inc. Steroid receptor modulator compounds and methods
BR9710988A (pt) 1996-06-27 2002-01-15 Ligand Pharm Inc Método e compostos moduladores receptores de androgênio
US6506766B1 (en) * 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6380207B2 (en) 1998-02-13 2002-04-30 Abbott Laboratories Glucocortiocoid-selective antiinflammatory agents
DE69904804T2 (de) * 1998-02-13 2003-11-06 Abbott Laboratories, Abbott Park Glucocorticoid selektive entzündungshemmende mittel
US6093826A (en) * 1998-06-08 2000-07-25 Ligand Pharmaceuticals Incorporated Process for the preparation of C(5)-substituted 1,2-dihydro-5H-chromeno[3,4-f] quinolines
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AU2003258050A1 (en) 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
EP1558618A1 (en) 2002-10-11 2005-08-03 Ligand Pharmaceuticals, Inc. 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS

Similar Documents

Publication Publication Date Title
CN107485612B (zh) 咪唑并吡啶化合物及其用途
ES2568015T3 (es) Derivado de pirazoloquinolina como inhibidores de PDE9
JP2005529089A5 (enExample)
WO2012084711A1 (en) N-substituted azetidine derivatives
RS57106B1 (sr) Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora
EP3312184A1 (en) Piperidine derivative and preparation method and pharmaceutical use thereof
JP2008530030A (ja) 新規なチューブリン重合阻害剤
WO2008021337A1 (en) Oxazinan-2-one derivatives useful as pr modulators
BR112015004637B1 (pt) Derivados de imidazolina, seus usos e seus processos de preparação, e composição farmacêutica
TW200536849A (en) Substituted heterocycles and the uses thereof
JP2015178458A (ja) ベンゼン環縮合含窒素5員複素環式化合物、またはその薬理学的に許容される塩
KR20130098269A (ko) 테트라히드로카르볼린 유도체
HK1223355A1 (zh) 作为ep4配体的苯并咪唑衍生物
WO2023207556A1 (zh) Prmt5-mta抑制剂
JP2021508318A (ja) チューブリン阻害剤
CN111511736B (zh) 含氮6元环化合物
WO2008021339A2 (en) Pyrrolidine and related derivatives useful as pr modulators
WO2011013624A1 (ja) インドール誘導体、またはその薬理学的に許容される塩
CA2660166C (fr) Nouveaux derives imidazolones, leur preparation a titre de medicaments, compositions pharmaceutiques, utilisation comme inhibiteurs de proteines kinases notamment cdc7
JP2006504737A5 (enExample)
CN112047944A (zh) 一种选择性抑制激酶化合物及其用途
JP2022515890A (ja) エストロゲン受容体タンパク質分解薬
CN113518779B (zh) 噻吩并杂环类衍生物、其制备方法及其在医药上的应用
CA3104956A1 (en) Novel lxr modulators with bicyclic core moiety
TW201623275A (zh) 噻吩並環烷基或噻吩並雜環基類衍生物、其製備方法及其在醫藥上的應用